Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis
- PMID: 26776937
- DOI: 10.1016/j.eururo.2015.12.045
Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis
Abstract
Prostate-specific antigen (PSA) is frequently used in isolation to guide treatment decisions in men with recurrent prostate cancer, a practice discouraged by prostate cancer working groups and guidelines. Instead, PSA should be used with imaging and other factors to make treatment decisions.
Published by Elsevier B.V.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
